An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.
Completed
Conditions studied: Lymphoma
In brief
The purpose of this study is to examine the association with EBV infection, monitor the occurrence of lymphoma and assess lymphoma risk in patients with rheumatoid arthritis and/or Crohns disease and you have taken infliximab.
Key facts
- Study ID
- NCT00440817
- Run by
- Centocor Ortho Biotech Services, L.L.C.
- People needed
- 120
- Starts
- 2006-02-01
- Expected to finish
- 2006-08-01
- Last updated by the study team
- 2014-04-10
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with Crohns disease or rheumatoid arthritis who participate in the specified registries will be included in the analysis. For the lymphoma analysis, patients must be recorded as having a lymphoma during their participation in one of these registries
You may not qualify if…
- Patients who do not have Crohns disease or rheumatoid arthritis and who did not participate in one of the identified registries will be excluded from the study
Where it is running
- Study site — Highland Park, Illinois, United States
- Study site — Wichita, Kansas, United States
- Study site — Albany, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.